Literature DB >> 31958143

Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival.

S V Ward1,2, D C Gibbs3, I Orlow2, N E Thomas4, P A Kanetsky5, L Luo6, A E Cust7, H Anton-Culver8, S B Gruber9, R P Gallagher10, S Rosso11, R Zanetti11, T Dwyer12,13, C B Begg2, M Berwick6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31958143      PMCID： PMC7334062          DOI： 10.1111/bjd.18881

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

1.  A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma.

Authors:  Colin B Begg; Amanda J Hummer; Urvi Mujumdar; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Stephen B Gruber; Hoda Anton Culver; Roberto Zanetti; Richard P Gallagher; Terrence Dwyer; Timothy R Rebbeck; Klaus Busam; Lynn From; Marianne Berwick
Journal:  Int J Epidemiol       Date:  2006-03-23       Impact factor: 7.196

2.  Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter.

Authors:  Mijke Visser; Robert-Jan Palstra; Manfred Kayser
Journal:  Hum Mol Genet       Date:  2015-01-27       Impact factor: 6.150

3.  IRF4 rs12203592 functional variant and melanoma survival.

Authors:  Miriam Potrony; Aida Rebollo-Morell; Pol Giménez-Xavier; Lisa Zimmer; Joan Anton Puig-Butille; Gemma Tell-Marti; Antje Sucker; Celia Badenas; Cristina Carrera; Josep Malvehy; Dirk Schadendorf; Susana Puig
Journal:  Int J Cancer       Date:  2017-02-06       Impact factor: 7.396

4.  Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.

Authors:  D C Gibbs; S V Ward; I Orlow; G Cadby; P A Kanetsky; L Luo; K J Busam; A Kricker; B K Armstrong; A E Cust; H Anton-Culver; R P Gallagher; R Zanetti; S Rosso; L Sacchetto; D W Ollila; C B Begg; M Berwick; N E Thomas
Journal:  Br J Dermatol       Date:  2017-10-06       Impact factor: 9.302

5.  Telomerase activity in prognostic histopathologic features of melanoma.

Authors:  Lucia Carvalho; Monica Lipay; Francisco Belfort; Ivan Santos; Joyce Andrade; Alessandra Haddad; Flavia Brunstein; Lydia Ferreira
Journal:  J Plast Reconstr Aesthet Surg       Date:  2006-04-03       Impact factor: 2.740

6.  The Western Australian Melanoma Health Study: study design and participant characteristics.

Authors:  Sarah V Ward; Gemma Cadby; Amanda Lee; Judith M Cole; Jane S Heyworth; Michael J Millward; Fiona M Wood; Lyle J Palmer
Journal:  Cancer Epidemiol       Date:  2011-04-06       Impact factor: 2.984

7.  Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Henry R Bose
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272
  7 in total
  1 in total

1.  Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study.

Authors:  Danielle R Davari; Irene Orlow; Peter A Kanetsky; Li Luo; Klaus J Busam; Ajay Sharma; Anne Kricker; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; David C Gibbs; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  Curr Oncol       Date:  2021-11-16       Impact factor: 3.677
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.